Do analysts rate VIVS or BNGO?

Bionano Genomics has a consensus price target of $6.00, suggesting a potential upside of 391.80%. Given Bionano Genomics' stronger consensus rating and higher possible upside, analysts plainly believe Bionano Genomics is more favorable than VivoSim Labs. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VivoSim Labs 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Bionano Genomics 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is VIVS or BNGO more profitable?

Bionano Genomics has a net margin of -106.58% compared to VivoSim Labs' net margin of -11,016.07%. Bionano Genomics' return on equity of -78.78% beat VivoSim Labs' return on equity. Company Net Margins Return on Equity Return on Assets VivoSim Labs -11,016.07% -612.23% -177.02% Bionano Genomics -106.58% -78.78% -48.54%

Do analysts rate BFRG or VIVS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bullfrog AI 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 VivoSim Labs 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is BFRG or VIVS more profitable?

Bullfrog AI has a net margin of 0.00% compared to VivoSim Labs' net margin of -11,016.07%. Bullfrog AI's return on equity of -150.36% beat VivoSim Labs' return on equity. Company Net Margins Return on Equity Return on Assets Bullfrog AI N/A -150.36% -127.98% VivoSim Labs -11,016.07% -612.23% -177.02%

Do analysts prefer ISPC or VIVS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iSpecimen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 VivoSim Labs 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, ISPC or VIVS?

iSpecimen has higher revenue and earnings than VivoSim Labs. VivoSim Labs is trading at a lower price-to-earnings ratio than iSpecimen, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio iSpecimen $1.93M 2.01 -$10.49M -$56.44 N/A VivoSim Labs $130K 37.19 -$13.84M -$4.47 N/A

Is ISPC or VIVS more profitable?

iSpecimen has a net margin of -2,445.40% compared to VivoSim Labs' net margin of -11,016.07%. iSpecimen's return on equity of -524.39% beat VivoSim Labs' return on equity. Company Net Margins Return on Equity Return on Assets iSpecimen -2,445.40% -524.39% -140.42% VivoSim Labs -11,016.07% -612.23% -177.02%

Do analysts rate VIVS or TBIO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VivoSim Labs 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Telesis Bio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is VIVS or TBIO more profitable?

Telesis Bio has a net margin of -336.59% compared to VivoSim Labs' net margin of -11,016.07%. Telesis Bio's return on equity of 0.00% beat VivoSim Labs' return on equity. Company Net Margins Return on Equity Return on Assets VivoSim Labs -11,016.07% -612.23% -177.02% Telesis Bio -336.59% N/A -61.89%

Do analysts recommend BFRGW or VIVS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bullfrog AI 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 VivoSim Labs 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation and earnings, BFRGW or VIVS?

Bullfrog AI has higher revenue and earnings than VivoSim Labs. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bullfrog AI $298.80K N/A N/A N/A N/A VivoSim Labs $130K 37.19 -$13.84M -$4.47 N/A

Is BFRGW or VIVS more profitable?

Bullfrog AI has a net margin of 0.00% compared to VivoSim Labs' net margin of -11,016.07%. Bullfrog AI's return on equity of 0.00% beat VivoSim Labs' return on equity. Company Net Margins Return on Equity Return on Assets Bullfrog AI N/A N/A N/A VivoSim Labs -11,016.07% -612.23% -177.02%

VivoSim Labs (VIVS) Competitors

$0.29 +0.01 (+2.14%)

Closing price 08/31/2026 04:00 PM Eastern

Extended Trading

$0.30 +0.00 (+1.24%)

As of 04:52 AM Eastern

Compare

VIVS vs. BNGO, BFRG, ISPC, TBIO, and BFRGW

Should you buy VivoSim Labs stock or one of its competitors? VivoSim Labs's main competitors and comparable companies include Bionano Genomics (BNGO), Bullfrog AI (BFRG), iSpecimen (ISPC), Telesis Bio (TBIO), and Bullfrog AI (BFRGW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does VivoSim Labs compare to Bionano Genomics?

VivoSim Labs (NASDAQ:VIVS) and Bionano Genomics (NASDAQ:BNGO) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, earnings, dividends, analyst recommendations and institutional ownership.

VivoSim Labs has a beta of 1.47, suggesting that its share price is 47% more volatile than the broader market. Comparatively, Bionano Genomics has a beta of 1.63, suggesting that its share price is 63% more volatile than the broader market.

VivoSim Labs has higher earnings, but lower revenue than Bionano Genomics. Bionano Genomics is trading at a lower price-to-earnings ratio than VivoSim Labs, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VivoSim Labs	$130K	37.19	-$13.84M	-$4.47	N/A
Bionano Genomics	$28.51M	0.50	-$26.40M	-$3.02	N/A

Bionano Genomics has a consensus price target of $6.00, suggesting a potential upside of 391.80%. Given Bionano Genomics' stronger consensus rating and higher possible upside, analysts plainly believe Bionano Genomics is more favorable than VivoSim Labs.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
VivoSim Labs	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Bionano Genomics	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

8.2% of VivoSim Labs shares are held by institutional investors. Comparatively, 11.4% of Bionano Genomics shares are held by institutional investors. 1.0% of VivoSim Labs shares are held by company insiders. Comparatively, 0.7% of Bionano Genomics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Bionano Genomics has a net margin of -106.58% compared to VivoSim Labs' net margin of -11,016.07%. Bionano Genomics' return on equity of -78.78% beat VivoSim Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
VivoSim Labs	-11,016.07%	-612.23%	-177.02%
Bionano Genomics	-106.58%	-78.78%	-48.54%

In the previous week, VivoSim Labs and VivoSim Labs both had 1 articles in the media. VivoSim Labs' average media sentiment score of 1.87 beat Bionano Genomics' score of 0.94 indicating that VivoSim Labs is being referred to more favorably in the media.

Company	Overall Sentiment
VivoSim Labs	Very Positive
Bionano Genomics	Positive

Summary

Bionano Genomics beats VivoSim Labs on 10 of the 15 factors compared between the two stocks.

How does VivoSim Labs compare to Bullfrog AI?

Bullfrog AI (NASDAQ:BFRG) and VivoSim Labs (NASDAQ:VIVS) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability.

Bullfrog AI has a beta of -2.7, suggesting that its stock price is 370% less volatile than the broader market. Comparatively, VivoSim Labs has a beta of 1.47, suggesting that its stock price is 47% more volatile than the broader market.

In the previous week, Bullfrog AI and Bullfrog AI both had 1 articles in the media. VivoSim Labs' average media sentiment score of 1.87 beat Bullfrog AI's score of 0.93 indicating that VivoSim Labs is being referred to more favorably in the news media.

Company	Overall Sentiment
Bullfrog AI	Positive
VivoSim Labs	Very Positive

Bullfrog AI has higher earnings, but lower revenue than VivoSim Labs. Bullfrog AI is trading at a lower price-to-earnings ratio than VivoSim Labs, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bullfrog AI	$120K	82.67	-$6.50M	-$0.46	N/A
VivoSim Labs	$130K	37.19	-$13.84M	-$4.47	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bullfrog AI	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
VivoSim Labs	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Bullfrog AI has a net margin of 0.00% compared to VivoSim Labs' net margin of -11,016.07%. Bullfrog AI's return on equity of -150.36% beat VivoSim Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bullfrog AI	N/A	-150.36%	-127.98%
VivoSim Labs	-11,016.07%	-612.23%	-177.02%

1.0% of Bullfrog AI shares are held by institutional investors. Comparatively, 8.2% of VivoSim Labs shares are held by institutional investors. 14.7% of Bullfrog AI shares are held by company insiders. Comparatively, 1.0% of VivoSim Labs shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Bullfrog AI beats VivoSim Labs on 8 of the 13 factors compared between the two stocks.

How does VivoSim Labs compare to iSpecimen?

iSpecimen (NASDAQ:ISPC) and VivoSim Labs (NASDAQ:VIVS) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, institutional ownership, analyst recommendations, risk, valuation, media sentiment, dividends and profitability.

13.6% of iSpecimen shares are held by institutional investors. Comparatively, 8.2% of VivoSim Labs shares are held by institutional investors. 12.2% of iSpecimen shares are held by company insiders. Comparatively, 1.0% of VivoSim Labs shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

iSpecimen has a net margin of -2,445.40% compared to VivoSim Labs' net margin of -11,016.07%. iSpecimen's return on equity of -524.39% beat VivoSim Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iSpecimen	-2,445.40%	-524.39%	-140.42%
VivoSim Labs	-11,016.07%	-612.23%	-177.02%

iSpecimen has higher revenue and earnings than VivoSim Labs. VivoSim Labs is trading at a lower price-to-earnings ratio than iSpecimen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iSpecimen	$1.93M	2.01	-$10.49M	-$56.44	N/A
VivoSim Labs	$130K	37.19	-$13.84M	-$4.47	N/A

In the previous week, iSpecimen and iSpecimen both had 1 articles in the media. iSpecimen's average media sentiment score of 1.89 beat VivoSim Labs' score of 1.87 indicating that iSpecimen is being referred to more favorably in the media.

Company	Overall Sentiment
iSpecimen	Very Positive
VivoSim Labs	Very Positive

iSpecimen has a beta of 1.66, suggesting that its stock price is 66% more volatile than the broader market. Comparatively, VivoSim Labs has a beta of 1.47, suggesting that its stock price is 47% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iSpecimen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
VivoSim Labs	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

iSpecimen beats VivoSim Labs on 10 of the 12 factors compared between the two stocks.

How does VivoSim Labs compare to Telesis Bio?

VivoSim Labs (NASDAQ:VIVS) and Telesis Bio (NASDAQ:TBIO) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk, analyst recommendations, media sentiment, profitability, valuation and dividends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
VivoSim Labs	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Telesis Bio	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

8.2% of VivoSim Labs shares are held by institutional investors. Comparatively, 37.6% of Telesis Bio shares are held by institutional investors. 1.0% of VivoSim Labs shares are held by insiders. Comparatively, 24.5% of Telesis Bio shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

VivoSim Labs has higher earnings, but lower revenue than Telesis Bio. VivoSim Labs is trading at a lower price-to-earnings ratio than Telesis Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VivoSim Labs	$130K	37.19	-$13.84M	-$4.47	N/A
Telesis Bio	$225.09M	0.00	-$47.72M	-$20.52	N/A

Telesis Bio has a net margin of -336.59% compared to VivoSim Labs' net margin of -11,016.07%. Telesis Bio's return on equity of 0.00% beat VivoSim Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
VivoSim Labs	-11,016.07%	-612.23%	-177.02%
Telesis Bio	-336.59%	N/A	-61.89%

In the previous week, VivoSim Labs and VivoSim Labs both had 1 articles in the media. VivoSim Labs' average media sentiment score of 1.87 beat Telesis Bio's score of 0.00 indicating that VivoSim Labs is being referred to more favorably in the media.

Company	Overall Sentiment
VivoSim Labs	Very Positive
Telesis Bio	Neutral

VivoSim Labs has a beta of 1.47, suggesting that its share price is 47% more volatile than the broader market. Comparatively, Telesis Bio has a beta of 2.45, suggesting that its share price is 145% more volatile than the broader market.

Summary

Telesis Bio beats VivoSim Labs on 8 of the 13 factors compared between the two stocks.

How does VivoSim Labs compare to Bullfrog AI?

Bullfrog AI (NASDAQ:BFRGW) and VivoSim Labs (NASDAQ:VIVS) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bullfrog AI	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
VivoSim Labs	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Bullfrog AI has higher revenue and earnings than VivoSim Labs.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bullfrog AI	$298.80K	N/A	N/A	N/A	N/A
VivoSim Labs	$130K	37.19	-$13.84M	-$4.47	N/A

Bullfrog AI has a net margin of 0.00% compared to VivoSim Labs' net margin of -11,016.07%. Bullfrog AI's return on equity of 0.00% beat VivoSim Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bullfrog AI	N/A	N/A	N/A
VivoSim Labs	-11,016.07%	-612.23%	-177.02%

In the previous week, Bullfrog AI had 1 more articles in the media than VivoSim Labs. MarketBeat recorded 2 mentions for Bullfrog AI and 1 mentions for VivoSim Labs. VivoSim Labs' average media sentiment score of 1.87 beat Bullfrog AI's score of 0.93 indicating that VivoSim Labs is being referred to more favorably in the news media.

Company	Overall Sentiment
Bullfrog AI	Positive
VivoSim Labs	Very Positive

8.2% of VivoSim Labs shares are owned by institutional investors. 1.0% of VivoSim Labs shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Bullfrog AI beats VivoSim Labs on 5 of the 9 factors compared between the two stocks.

Get VivoSim Labs News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VIVS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

VIVS vs. The Competition

Export

Metric	VivoSim Labs	Life Sciences Tools & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$4.73M	$10.11B	$7.20B	$12.89B
Dividend Yield	N/A	1.46%	2.54%	11.27%
P/E Ratio	-0.07	62.94	272.61	25.48
Price / Sales	37.19	114.07	626.66	97.10
Price / Cash	N/A	26.70	28.74	36.03
Price / Book	-0.69	5.46	11.05	6.34
Net Income	-$13.84M	$56.67B	$3.47B	$349.45M
7 Day Performance	-0.07%	-1.72%	0.25%	-0.65%
1 Month Performance	-15.44%	8.21%	8.27%	4.48%
1 Year Performance	-88.06%	24.21%	24.14%	14.89%

VivoSim Labs Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
VIVS VivoSim Labs	0.3331 of 5 stars	$0.29 +2.1%	N/A	-88.1%	$4.73M	$130K	N/A	20	Gap Down
BNGO Bionano Genomics	2.2863 of 5 stars	$1.21 flat	$6.00 +395.9%	-67.6%	$14.25M	$28.51M	N/A	300
BFRG Bullfrog AI	1.2785 of 5 stars	$0.57 -1.0%	N/A	-55.8%	$10.59M	$120K	N/A	4
ISPC iSpecimen	0.9127 of 5 stars	$1.60 -2.4%	N/A	-94.6%	$4.13M	$466.30K	N/A	60
TBIO Telesis Bio	N/A	$0.00 flat	N/A	-91.7%	$2K	$225.09M	N/A	200	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:VIVS) was last updated on 9/1/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

VivoSim Labs (VIVS) Competitors

VIVS vs. BNGO, BFRG, ISPC, TBIO, and BFRGW

How does VivoSim Labs compare to Bionano Genomics?

Summary

How does VivoSim Labs compare to Bullfrog AI?

Summary

How does VivoSim Labs compare to iSpecimen?

Summary

How does VivoSim Labs compare to Telesis Bio?

Summary

How does VivoSim Labs compare to Bullfrog AI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

VIVS vs. The Competition

VivoSim Labs Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

VivoSim Labs (VIVS) Competitors

VIVS vs. BNGO, BFRG, ISPC, TBIO, and BFRGW

How does VivoSim Labs compare to Bionano Genomics?

Which has more volatility & risk, VIVS or BNGO?

Which has stronger valuation and earnings, VIVS or BNGO?

Do analysts rate VIVS or BNGO?

Do institutionals and insiders have more ownership in VIVS or BNGO?

Is VIVS or BNGO more profitable?

Does the media refer more to VIVS or BNGO?

Summary

How does VivoSim Labs compare to Bullfrog AI?

Which has more volatility and risk, BFRG or VIVS?

Does the media refer more to BFRG or VIVS?

Which has higher valuation & earnings, BFRG or VIVS?

Do analysts rate BFRG or VIVS?

Is BFRG or VIVS more profitable?

Do insiders & institutionals have more ownership in BFRG or VIVS?

Summary

How does VivoSim Labs compare to iSpecimen?

Do insiders and institutionals believe in ISPC or VIVS?

Is ISPC or VIVS more profitable?

Which has better valuation and earnings, ISPC or VIVS?

Does the media prefer ISPC or VIVS?

Which has more volatility and risk, ISPC or VIVS?

Do analysts prefer ISPC or VIVS?

Summary

How does VivoSim Labs compare to Telesis Bio?

Do analysts rate VIVS or TBIO?

Do insiders and institutionals have more ownership in VIVS or TBIO?

Which has preferable valuation & earnings, VIVS or TBIO?

Is VIVS or TBIO more profitable?

Does the media prefer VIVS or TBIO?

Which has more risk and volatility, VIVS or TBIO?

Summary

How does VivoSim Labs compare to Bullfrog AI?

Do analysts recommend BFRGW or VIVS?

Which has stronger valuation and earnings, BFRGW or VIVS?

Is BFRGW or VIVS more profitable?

Does the media refer more to BFRGW or VIVS?

Do insiders & institutionals hold more shares of BFRGW or VIVS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

VIVS vs. The Competition

VivoSim Labs Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools